Different activities of antitumor immunomodulators to induce neutrophil adherence response.

Tanaka M, Abe S

Drug Discov Ther. 2019; 13(6):299-305.

DOI: 10.5582/ddt.2019.01065

Summary Full Text (PDF)

Gene disruption of ribosomal protein L5 (RPL5) decreased the sensitivity of CHO-K1 cells to uncoupler carbonylcyanide-3-chlorophenylhydrazone.

Araki M, Ishibashi T, Munesue M, Ohashi K, Nobukuni Y, Maeda M

Drug Discov Ther. 2019; 13(6):306-313.

DOI: 10.5582/ddt.2019.01080

Summary Full Text (PDF)

Inhibitions of human parainfluenza virus type 2 replication by ribavirin and mycophenolate mofetil are restored by guanosine and S-(4-nitrobenzyl)-6-thioinosine.

Uematsu J, Sakai-Sugino K, Kihira-Nakanishi S, Yamamoto H, Hirai K, Kawano M, Nishio M, Tsurudome M, O’Brien M, Komada H

Drug Discov Ther. 2019; 13(6):314-321.

DOI: 10.5582/ddt.2019.01084

Summary Full Text (PDF)

Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus.

Sugimoto K, Abe I, Minezaki M, Takashi Y, Ochi K, Fujii H, Ohishi H, Yamao Y, Kudo T, Ohe K, Abe M, Ohnishi Y, Shinagawa T, Mukoubara S, Kobayashi K

Drug Discov Ther. 2019; 13(6):322-327.

DOI: 10.5582/ddt.2019.01085

Summary Full Text (PDF)

Safflower seed extract synergizes the therapeutic effect of cisplatin and reduces cisplatin-induced nephrotoxicity in human colorectal carcinoma RKO cells and RKO-transplanted mice.

Park CH, Kim MJ, Yang CY, Yokozawa T, Shin YS

Drug Discov Ther. 2019; 13(6):328-334.

DOI: 10.5582/ddt.2019.01086

Summary Full Text (PDF)

Methanol extract of Lonicera caerulea var. emphyllocalyx fruit has anti-motility and anti-biofilm activity against enteropathogenic Escherichia coli.

Minami M, Takase H, Nakamura M, Makino T

Drug Discov Ther. 2019; 13(6):335-342.

DOI: 10.5582/ddt.2019.01087

Summary Full Text (PDF)

Janus microspheres for enhanced enteral drug delivery: Preparation and orientated attachment to a Caco-2 monolayer.

Matsumoto A, Watanabe C, Murakami M

Drug Discov Ther. 2019; 13(6):343-353.

DOI: 10.5582/ddt.2019.01090

Summary Full Text (PDF)

FADS2 and ELOVL6 mutation frequencies in Japanese Crohn's disease patients.

Motoi Y, Ito Z, Suzuki S, Takami S, Matsuo K, Sato M, Ota Y, Tsuruta M, Kojima M, Noguchi M, Uchiyama K, Kubota T

Drug Discov Ther. 2019; 13(6):354-359.

DOI: 10.5582/ddt.2019.01081

Summary Full Text (PDF)

Feasibility of microbial sample collection on the skin from people in Yaoundé, Cameroon.

Benderli NC, Ogai K, Lloyd YM, Arios JP, Jiyarom B, Awanakam AH, Esemu LF, Hori A, Megnekou R, Leke RGF, Kuraishi T, Okamoto S, Ekali GL

Drug Discov Ther. 2019; 13(6):360-364.

DOI: 10.5582/ddt.2019.01075

Summary Full Text (PDF)

"4+7" city drug volume-based purchasing and using pilot program in China and its impact.

Tang M, He JJ, Chen MX, Cong LX, Xu Y, Yang Y, Hou ZY, Song PP, Jin CL

Drug Discov Ther. 2019; 13(6):365-369.

DOI: 10.5582/ddt.2019.01093

Summary Full Text (PDF)